Related by context. Frequent words. (Click for all words.) 65 advanced adenomas 65 haematological 64 KRAS mutations 64 poor metabolizers 63 colorectal carcinoma 63 breast carcinoma 62 distant metastasis 62 QTc prolongation 62 biochemical recurrence 62 HSCT 62 pancreatic adenocarcinoma 61 GISTs 61 Secondary endpoints included 61 histologic 61 CYP#C# [001] 61 HBsAg 61 cytogenetic response 61 NGAL 61 fluvastatin 61 multiple myeloma MM 61 atherothrombosis 60 KRAS mutation 60 immunohistochemical 60 complete cytogenetic 60 prospectively defined 60 HNSCC 60 platelet reactivity 60 renal tumors 59 carotid stenosis 59 pericardial effusion 59 lymph node metastasis 59 liver biopsies 59 ARCOXIA 59 prognostic markers 59 MGUS 59 immunostaining 59 neoadjuvant therapy 59 K ras 59 achieved statistical significance 59 liver transplant recipients 59 Metastases 59 Angiographic 59 Secondary endpoints include 59 Secondary endpoints 59 carcinoid 59 % CI #.#-#.# [003] 59 CMV infection 58 HNPCC 58 adenocarcinomas 58 carcinoid tumors 58 FOLFOX4 58 neovascular 58 mCRC patients 58 hepatocellular carcinoma HCC 58 histopathologic 58 pharmacokinetic parameters 58 confidence interval #.#-#.# 58 VKORC1 58 posttreatment 58 allogeneic stem cell 58 tumor resection 58 ximelagatran 58 echocardiographic 58 ERCC1 58 Thrombin 58 serologic 58 pancreatic neuroendocrine tumors 58 hepatocellular cancer 58 univariate analysis 58 cardiac dysfunction 58 paroxysmal nocturnal hemoglobinuria 58 thromboembolic events 58 refractory chronic lymphocytic 58 ependymoma 58 myeloproliferative disorders 58 bladder cancers 58 histopathological 58 cytological 58 non squamous 58 EGFR mutations 58 K RAS 58 PCa 58 metastatic lesions 58 malignant pleural mesothelioma 58 Asymptomatic 58 clinically meaningful improvement 58 T#I [002] 57 microalbuminuria 57 Pharmacokinetic 57 hematopoietic cell 57 lymph node involvement 57 T2DM 57 paclitaxel eluting stents 57 lobular carcinoma 57 non squamous NSCLC 57 leukemia ALL 57 pheochromocytoma 57 Immunohistochemistry 57 gastrointestinal stromal tumors GIST 57 efalizumab 57 cell adhesion molecule